Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia By Ogkologos - March 26, 2026 260 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RECITE study Source RELATED ARTICLESMORE FROM AUTHOR Perioperative Durvalumab Plus FLOT Improves OS in Patients with Resectable Gastric or GEJ Adenocarcinoma Advancing Childhood Cancer Research: A Conversation with Dr. Brigitte Widemann Azacitidine-Venetoclax Prolongs EFS Over Induction Chemotherapy Among Induction-Eligible Patients with AML MOST POPULAR Immunotherapy’s Skin Side Effects: Are Microbes to Blame? July 13, 2022 Oligoprogression in Metastatic NSCLC Could Be Effectively Treated with SBRT Plus... December 21, 2023 Cancer in My Community: Expanding Access to Genetic Testing in Mexico September 1, 2020 FDA Grants Accelerated Approval to Dostarlimab-gxly for dMMR Endometrial Cancer April 23, 2021 Load more HOT NEWS Synchronized Swimmer Learns She Has Breast Cancer After Teammate Kicks Her... EMA Recommends Granting a Marketing Authorisation for Vimseltinib Staging at Presentation for Patients with Localised Pancreatic Ductal Adenocarcinoma Should... Why consistent and funded cancer policies are key to improving cancer...
